China Resources Pharmaceutical Group Ltd

Common Name

CR Pharma

Country

Hong Kong

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

86,000

Ticker

3320

Exchange

HONG KONG EXCHANGES AND CLEARING LTD

Website

www.crpharm.com

Description

China Resources Pharmaceutical Group Limited is a prominent pharmaceutical company that operates extensively within the Chinese healthcare market. It engages in the research, development, manufacturin... Show more

Financial Statements of CR Pharma

Below are the financial statements of CR Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of CNY	2024	2023
Non-current assets	—	—
Property, plant and equipment	20.99^a	20.12^a
Right-of-use assets	4.92^a	4.93^a
Investment properties	1.67^a	1.69^a
Intangible assets	8.51^a	8.02^a
Goodwill	22.37^a	21.45^a
Interests in associates	5.54^a	6.01^a
Interests in joint ventures	0.02^a	0.03^a
Other non-current financial assets	0.58^a	0.84^a
Deferred tax assets	1.97^a	1.77^a
Other non-current assets	5.34^a	3.34^a
Total non-current assets	71.91^a	68.2^a
Current assets	—	—
Inventories	37.05^a	31.88^a
Trade and other receivables	93.93^a	79.19^a
Other current financial assets	28.21^a	34.62^a
Amounts due from related parties	1.26^a	1.06^a
Tax recoverable	0.22^a	0.12^a
Pledged and term deposits	8.7^a	7.02^a
Cash and cash equivalents	16.42^a	24.65^a
Assets classified as held for sale	0.04^a	0.04^a
Total current assets	185.85^a	178.57^a
Current liabilities	—	—
Trade and other payables	80.74^a	79.08^a
Contract liabilities	4.22^a	4.02^a
Lease liabilities	0.52^a	0.46^a
Amounts due to related parties	0.88^a	4.12^a
Bank borrowings	42.7^a	43.12^a
Bonds payable	2.15^a	2.64^a
Tax payable	0.95^a	0.73^a
Defined benefit obligations	0.05^a	0.06^a
Total current liabilities	132.22^a	134.23^a
Net current assets	53.62^a	44.34^a
Total assets less current liabilities	125.54^a	112.54^a
Non-current liabilities	—	—
Bank borrowings	17.87^a	11.09^a
Bonds payable	5^a	4^a
Lease liabilities	0.77^a	0.84^a
Deferred tax liabilities	1.92^a	1.72^a
Defined benefit obligations	0.77^a	0.76^a
Amounts due to related parties	0^a	0.04^a
Other non-current liabilities	1.13^a	1.1^a
Total non-current liabilities	27.45^a	19.56^a
Net assets	98.09^a	92.97^a
Capital and reserves	—	—
Share capital	24.63^a	24.63^a
Reserves	23.61^a	21.33^a
Total equity attributable to equity shareholders of the company	48.24^a	45.96^a
Non-controlling interests	49.84^a	47.02^a
Total equity	98.09^a	92.97^a

Download Data

Verified Sources Behind CR Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CR Pharma’s data sources below and access millions more through our Disclosure Search.

a. CR Pharma's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

China Resources Pharmaceutical Group Ltd

Financial Statements of CR Pharma

Verified Sources Behind CR Pharma’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

HUTCHMED (China) Ltd

Viatris Inc

Ipsen SA

Dr Reddy's Laboratories Ltd

Swedish Orphan Biovitrum AB (publ)

Alkem Laboratories Ltd